Home Screening of medicinal mushroom strains with antimicrobial activity and polysaccharides production
Article Open Access

Screening of medicinal mushroom strains with antimicrobial activity and polysaccharides production

  • Zhanar Narmuratova ORCID logo , Nina Bisko ORCID logo , Kairat Mustafin ORCID logo , Galeb Al-Maali ORCID logo , Alina Kerner ORCID logo , Svitlana Bondaruk ORCID logo , Zhanara Suleimenova ORCID logo , Aigul Kalieva ORCID logo , Nurlan Akhmetsadykov ORCID logo , Aigerim Zhakipbekova ORCID logo and Margarita Lomberg ORCID logo EMAIL logo
Published/Copyright: April 24, 2023
Download Article (PDF)
Turkish Journal of Biochemistry
From the journal Turkish Journal of Biochemistry Volume 48 Issue 3

Abstract

Objectives

This study aimed to determine the antimicrobial activity of culture fluid and mycelial mass of selected Hericium strains from the IBK Mushroom Culture Collection (Kyiv, Ukraine) against bacteria and fungi, as well as to evaluate the potential of these mushrooms for biomass and extracellular polysaccharides production.

Methods

The antimicrobial activity of ethyl acetate extracts of culture fluid and aqueous-ethyl extracts of mycelial mass for three Hericium species: Hericium cirrhatum IBK 2393, Hericium coralloides IBK 2332, and Hericium erinaceus IBK 2530 against Gram-positive Bacillus subtilis, Staphylococcus aureus, and Gram-negative Escherichia coli, Klebsiella pneumoniae, Pseudomonas aureginosa bacteria as well as Aspergillus niger, Penicillium polonicum, and Mucor globosus fungi by the disk diffusion method was conducted. Analysis of the minimum inhibitory concentration was carried out according to the broth dilution method.

Results

High antimicrobial activity of culture fluid extracts of Hericium mushroom species against S. aureus was established after 14–21 days of cultivation. No effects of Hericium extracts against A. niger, P. polonicum, and M. globosus were observed. On the 7th day of submerged cultivation, the studied strains produced the maximum yield of extracellular polysaccharides. The most promising extracellular polysaccharide (EPS) producers were strains of H. coralloides IBK 2332 (1.89 g/L) and H. erinaceus IBK 2530 (1.90 g/L). The maximal value of biomass was produced by H. cirrhatum IBK 2393 on the 21st day of submerged cultivation (17.45 g/L).

Conclusions

Hericium mushrooms have significant potential for the development of new drugs with health benefits properties.

Keywords: basidiomycetes; culture fluid; extracellular polysaccharide (EPS); Hericium ; minimum inhibitory concentration (MIC); mycelium

Introduction

Edible mushrooms have not only great nutritional value and taste but also various medicinal properties [1, 2]. Most basidiomycetes contain biologically active substances with antibacterial effects, such as polysaccharides, carotenoids, phenolic compounds, terpenoids, etc., in their fruiting bodies, mycelium, and culture fluid [3, 4].

One of the priority areas in biotechnology and experimental mycology is the search for new producers of biologically active substances from edible mushrooms of different ecological and trophic groups. One of the well-known edible mushrooms with medicinal properties confirmed by clinical studies is Hericium erinaceus (Bull.: Fr.) Pers. This fungus has been used in folk medicine, mainly in South-East Asia countries (China, Japan). Purified bioactive metabolites from the fruiting bodies or mycelium of H. erinaceus have biological activities such as antitumor, neuro- and gastroprotective, immunomodulatory, neurotrophic, antioxidant, antibacterial, hypoglycemic, and hepatoprotective [5, 6]. Among biologically active substances isolated from Hericium fungi are hericenones, erinacins, extracellular and endopolysaccharides, phenols, sterols, and others [2, 7]. From the moment of isolation of oncostatic polysaccharides from the fruiting bodies of some basidiomycetes, an active study of these compounds is being begun, as well as the search for their producers [8], [9], [10]. Polysaccharides obtained not only from fruiting bodies but also from submerged mycelium and culture fluid of Hericium fungi attracted much attention due to their strong pharmacological effect [11], [12], [13], [14].

At present, among Hericium fungi, H. erinaceus is the most studied. At the same time, there is little information about the secondary metabolites produced by other species of Hericium mushrooms. Only data about erinacine isolation from H. flagellum and corallocins from Hericium coralloides which are potential therapeutic agents for neurodegenerative disorders were reported [7, 15].

Antimicrobial properties of macromycetes, including Hericium fungi, have been studied in numerous works [16], [17], [18], [19], [20]. It was found that aqueous, ethanol, methanol, ethyl acetate extracts of fruit bodies, and mycelium of H. erinaceus have antimicrobial activity against a number of bacteria [16, 17, 19], [20], [21], [22]. The antibacterial activity of the culture liquid of H. erinaceus was also found [22]. Besides, H. erinaceus extract showed strong activity against Staphylococcus aureus [16, 20, 23]. It should be noted that most data provide information about the antibacterial activity of extracts from the H. erinaceus fruiting bodies, while there is little information about the antimicrobial activity of extracts from mycelium and liquid fluid of other species of Hericium fungi [22]. Along with the antibacterial effect, the antifungal activity of extracts of mycelium of Hericium species against Candida albicans and Cryptococcus neoformans has also been reported [24].

In search of new sources of antimicrobial producers, the aim of our work was to study the antimicrobial activity of culture fluid and mycelial mass of three strains of three Hericium species from the ІВК mushroom culture collection (Kyiv, Ukraine), selected after preliminary screening, as well as to evaluate the ability of Hericium fungi for biomass and extracellular polysaccharides production under submerged cultivation.

Materials and methods

Mushroom strains

Pure cultures of three species of Hericium fungi (Hericium cirrhatum 2393, H. coralloides 2332, H. erinaceus 2530) were obtained from the IBK Mushroom Culture Collection of the M.G. Kholodny Institute of Botany of the National Academy of Sciences of Ukraine (Table 1) [25]. All strains were maintained on agar wort medium and stored at 4 °C.

Table 1:

The studied species and strains of Hericium.

Species, ІВК strain number Origin and year of deposit
Hericium cirrhatum 2393 Isolated from a carpophore, Ukraine, Ivano-Frankivsk Region, Vorokhta, Carpathian National Nature Park, on Fagus sylvatica, 2015.
Hericium coralloides 2332 Isolated from a carpophore, Ukraine, Ivano-Frankivsk Region, Kosiv, Hutsulshchyna National Nature Park, Rocky Ridge, on Fagus sp. 2013.
Hericium erinaceus 2530 Obtained from Kharkiv Karazin National University, Kharkiv, Ukraine, 2017. Isolated from carpophore, Ukraine, Krim, Sebastopol region, Baydarskaya valley, vil. Peredovoe, on Fagus taurica, 2013.

A liquid glucose-peptone-yeast nutrient medium (GPY) was used for fungal cultivation (g/L): glucose – 25.0; peptone – 3.0; yeast extract – 2.0; KH2PO4 – 1.0; K2HPO4 – 1.0; MgSO4 7H2O – 0.25; pH 5.5.

The inoculum preparation was well described in our previous study [4]. Mycelium cultivation was carried out in 500 mL Erlenmeyer flasks with 100 mL of GPY liquid nutrient medium on an orbital shaker (120 rpm) at 25 ± 0.1 °C for 28 days.

Test microorganisms

Five bacterial strains and three fungal strains were tested in this research. Three Gram-negative bacteria include Escherichia coli (B-906), Klebsiella pneumoniae (M-123), and Pseudomonas aureginosa (B-900), two Gram-positive bacteria include S. aureus (B-918), Bacillus subtilis (B-901). All bacterial strains were obtained from the collection of the Faculty of Biotechnology and Microbiology of the National University of Food Technologies (Kyiv, Ukraine).

Fungal strains include Aspergillus niger (VURV-F 822), Penicillium polonicum (VURV-F 823) from the Collection of Microorganisms of Crop Research Institute (Prague, Czech Republic), and Mucor globosus (N-O18) from the collection of microorganisms of the Ukrainian Institute of Botany.

Mueller-Hinton Agar was used for growing bacteria (g/L): peptone, 17.0; starch - 15.0; yeast extract - 0.5; agar-agar, 17.0; pH 7. Bacteria were grown for 1 day at 37 ± 0.1 °C. Malt extract agar (MEA, Pronadisa, Spain) was used for the micromycetes growth. Micromycetes were grown for 5 days at 26 ± 0.1 °C.

Preparation of mushroom extracts

Strains of Hericium were cultivated for 7, 14, 21, and 28 days in submerged conditions on an orbital shaker. After that, mycelial biomass was separated from the liquid by filtration, washed with distilled water, and dried to constant weight at 60 °C. Obtained fungal biomass was extracted with 70 % ethanol in a ratio of 1:50 (w/v, biomass to ethanol) in an ultrasonic bath at 40 °C for 30 min and left for 24 h at 4 °C. After that, the extract was filtered and centrifuged for 20 min at 3,500 rpm to remove the biomass. The resulting extract was tested for antimicrobial activity [26].

To concentrate the antimicrobial substances in the culture fluid, the method of liquid-liquid extraction was used. Ethyl acetate was added at a ratio of 2:1. The resulting mixture was shaken for 10 min and left for 20 h at 4 °C. The ethyl acetate fraction was evaporated to dryness on a rotary evaporator [27]. The procedure was repeated three times. The resulting residue was weighed, dissolved in 70 % ethanol, and adjusted to a volume equal to 1/10 of the original culture liquid.

Antimicrobial assay

The antibacterial activity of biomass and culture fluid extracts of the studied strains was assayed by the disk diffusion method [27]. A small number of bacteria from a freshly grown colony was transferred by a microbiological loop into test tubes with sterile saline, shaken until a homogeneous suspension was obtained, and the density of the inoculum was adjusted to exactly 0.5 in accordance with the McFarland standard (5 × 106 cells/mL) [26]. The resulting suspension of bacteria from the calculation of 0.2 mL was applied evenly to the surface of the Muller-Hinton medium. Extracts (10 μL) were applied to standard Bio Merieux firm discs (6 mm in diameter), dried at 40 °C for 30 min, and placed on the surface of an agar medium, pre-inoculated with a bacterial or fungal test culture. After that, the agar plates were incubated under appropriate conditions depending on the studied microorganism (24 h at 37 °C for bacteria and 72 h at 26 °C for fungi). Antibacterial/antifungal analysis was performed by measuring the growth inhibition zone around the filter discs [27]. In all assays, antibiotic Gentamycin sulphate (40 mg/mL, Ukraine) was used as a positive control. The ethyl acetate for the experiment with culture fluid and 70 % ethanol for the experiment with mycelial biomass were used as negative controls.

Analysis of the minimum inhibitory concentration (MIC) was carried out according to the broth microdilution method [28]. The test was performed in a 96-well polystyrene microtiter plate (Colstar, USA). 50 μL of the Muller-Hinton medium containing the appropriate concentration of the mushroom extract was added to each well, except for the control ones. The extracts were diluted in a range from 2 up to 768 times. After that, a 50 μL suspension of microbial cells (5 × 106 cells/mL) was added to each well; the sterility control well contained 100 mL of the Muller-Hinton medium, and the growth control well had 50 mL of medium and 50 mL of the bacterial suspension. The test was carried out in triplicate; MIC was defined as the minimum extract concentration at which no growth was observed in any repeats.

Polysaccharide determination

The mycelial biomass (MB) was harvested by filtration through Whatman No.1 filter paper. It was dried in a hot air oven at 60 °C until constant weights were recorded. For the determination of EPS, the obtained culture fluid after mycelia removal was concentrated in a vacuum evaporator three times from the initial volume, precipitated with 96 % cooled ethanol in a ratio of 1:1 and placed in a refrigerator at 4 °C for 24 h. The precipitate was isolated from the supernatant by centrifugation at 8,000 g for 15 min. After separation, EPS was dried at 60 °С to constant weight. The yields of MB and EPS were expressed as the g dry weight/L of the culture liquid [29, 30].

Statistical analysis

All experiments were carried out in triplicate. All data were statistically processed for analysis. The Student’s t-test was applied to determine significance, and a p-value of <0.05 was considered statistically significant. The results were expressed as mean ± standard deviation using Excel 2010 (Microsoft Corporation, USA).

Results

Antibacterial and antifungal assay of Hericium fungi

The study of three Hericium species cultures (H. cirrhatum IBK 2393, H. coralloides IBK 2332, H. erinaceus IBK 2530) antibacterial activity and antifungal properties of culture fluid ethyl acetate extracts and mycelial mass aqueous-ethyl extracts against Gram-positive B. subtilis (B-901), S. aureus (B-918), and Gram-negative E. coli (B-906), K. pneumoniae (M-123), P. aureginosa (B-900) bacteria as well as A. niger (VURV-F 822), P. polonicum (VURV-F 823), and M. globosus (N-O18) fungi by the disk diffusion method was conducted. The mushroom strains were selected as a result of our preliminary antimicrobial screening of homogenized native mycelium and initial cultural liquid of 13 strains belonging to four Hericium species (H. abietis, H. cirrhatum, H. coralloides, and H. erinaceus) from the IBK Mushroom Culture Collection [31].

According to the results, none of the extracts showed any activity against test micromycete: A. niger, P. polonicum, and M. globosus under conducted cultivation conditions.

For all of the strains, we observed no antimicrobial activity of the homogenized mycelium and culture fluid after 7 days of submerged cultivation. It was also found that studied Hericium sp. strains did not show antimicrobial activity against test bacteria Pseudomonas aeruginosa and E. coli. An exception was only the culture fluid extracts from H. coralloides IBK 2332 against E. coli on the 21st day of incubation.

Insignificant activity against Gram-negative bacteria K. pneumoniae was observed in strains H. coralloides IBK 2332 and H. cirrhatum IBK 2393 on the 14th - 21st days of incubation; the diameters of the growth retardation zone were less than 10 mm. The antimicrobial activity of fungal extracts against Gram-positive B. subtilis was also manifested on the 14th - 21st day of cultivation. The highest antimicrobial activity against B. subtilis was found in the culture fluid of the H. erinaceus IBK 2530 on the 14th day of cultivation; the diameter of the growth retardation zone was 28.0 ± 0.1 mm.

Among Gram-positive bacteria, S. aureus was the most sensitive to fungal extracts (Table 2, Figure 1). Ethyl acetate extracts of the culture fluid of H. cirrhatum ІВК 2393 and H. erinaceus ІВК 2530 showed the highest antimicrobial activity on the 14th day of cultivation, the diameter of the growth retardation zone was around 30 mm. The best results with the highest antimicrobial activity in growth suppression of S. aureus demonstrated the culture fluid extracts of H. coralloides IBK 2332 on the 21st day of cultivation; the diameter of the growth retardation zone was 32.1 ± 0.1 mm. Overall, these results indicate that in all investigated strains on the 14th and 21st day of cultivation, the growth retardation zone for S. aureus exceeded the positive control values. In contrast to the culture fluid, aqueous-ethyl extracts of the mycelial mass showed twice less antimicrobial activity, except H. cirrhatum ІВК 2393 (Table 2).

Table 2:

Antimicrobial activity of culture fluid ethyl acetate extracts and mycelial mass aqueous-ethyl extracts of Hericium strains against Staphylococcus aureus.

Duration of cultivation, days 14 21
Strain Extracts Diameter of zone of inhibition, mm
Hericium cirrhatum CF 29.9 ± 0.5 28.3 ± 0.2c
ІВК 2393 MB 18.5 ± 0.2 21.0 ± 1.0c
Hericium coralloides CF 30.2 ± 0.2 32.1 ± 0.1 c
ІВК 2332 MB 12.5 ± 0.4 15.5 ± 0.5c
Hericium erinaceus CF 30.2 ± 0.1 28.0 ± 0.2c
ІВК 2530 MB 14.2 ± 0.3 14.0 ± 0.2
Control + a 18.8 ± 0.1
Control - b 0

  1. CF, ethyl acetate extracts of the culture fluid; MB, aqueous-ethyl extract of mycelial biomass. a Gentamycin sulphate, antibiotic solution; b ethyl acetate for experiment with culture fluid, 70 % ethanol for experiment with mycelial biomass. The maximum value is indicated in bold. All results are expressed as mean ± SD from three experiments (n=3). cThe values within the columns between 14 and 21 days of cultivation are significantly different (p≤0.05).

Figure 1: Antibacterial activity of ethyl acetate extract of Hericium species culture fluid against Staphylococcus aureus (negative control, the 7th, 14th, 21st days of cultivation).
Figure 1:

Antibacterial activity of ethyl acetate extract of Hericium species culture fluid against Staphylococcus aureus (negative control, the 7th, 14th, 21st days of cultivation).

The minimum inhibitory concentration of aqueous-ethyl extracts of Hericium fungi

For a better understanding of the prospects for the use of these extracts against bacterial pathogens, it is important to establish the minimum inhibitory concentrations of the extracts. The MIC is the lowest concentration of a sample that inhibits the visible growth of microorganisms. Since Hericium fungal extracts showed the maximal effect against S. aureus, therefore, MIC of this test culture was determined (Table 3). It was established that the extract of the H. cirrhatum biomass has the least inhibitory activity. So, the MIC for this extract was determined when it was diluted 6 times, which corresponds to the content of dry substances at the level of 1900 μg/mL. Extracts obtained from the biomass of H. Coralloides and H. erinaceus inhibited the growth of S. aureus at much higher dilutions, namely 96 times, the content of dry substances in these extracts was 130 μg/mL. The investigated extract of the culture liquid of H. erinaceus was more effective than the biomass extract of this mushroom; its MIC was 50 μg/mL.

Table 3:

Minimum inhibitory concentration (MIC) of extracts from biomass and liquid culture of Hericium fungi against Staphylococcus aureus (14 days of cultivation).

Strain Type of extraction Dilution MICa, µg/mL
H. cirrhatum ІВК 2393 biomass 6 1900
H. coralloides ІВК 2332 biomass 96 130
H. erinaceus ІВК 2530 biomass 96 130
liquid culture 96 50

  1. aConcentration was calculated in accordance with the content of dry matter in extracts.

Accumulation of biomass and extracellular polysaccharide production of Hericium fungi

Analyzing the data obtained, we note that all studied Hericium sp. strains synthesized extracellular polysaccharides in the glucose-peptone-yeast nutrient medium (Table 4).

Table 4:

Accumulation of biomass and exopolysaccharides in Hericium fungi.

Strain Time, days Biomass, g/L Exopolysaccharides, g/L
Hericium cirrhatum

ІВК 2393		 7 4.16 ± 0.56 1.55 ± 0.06
14 8.27 ± 0.29a 1.33 ± 0.02a
21 17.45 ± 0.71 a 0.53 ± 0.11a
28 8.29 ± 0.9a 0.43 ± 0.05a
Hericium coralloides

ІВК 2332		 7 5.59 ± 1.06 1.89 ± 0.12
14 11.53 ± 1.09 a 0.9 ± 0.13a
21 12.10 ± 0.64 a 0.55 ± 0.06a
28 7.19 ± 0.31a 0.38 ± 0.05a
Hericium erinaceus

ІВК 2530		 7 2.31 ± 0.39 1.90 ± 0.07
14 6.23 ± 0.1a 1.75 ± 0.1
21 8.04 ± 0.42 a 0.39 ± 0.05a
28 7.48 ± 0.11a 0.25 ± 0.03a

  1. The maximum value is indicated in bold. All results are expressed as mean ± SD from three experiments (n=3). aThe values within the rows in comparison with data obtained on the 7th day are significantly different (p≤0.05).

In general, it is shown that for all strains, an increase in the accumulation of biomass was observed from 7 to 21 days of the cultivation period. Another important finding was that, at the same time, with an increase in the duration of cultivation, a decrease in the content of EPS was observed. The maximal value of biomass was produced by H. cirrhatum IBK 2393 on the 21st day of submerged cultivation - 17.45 ± 0.71 g/L. The maximum concentration of biomass produced by H. coralloides IBK 2332–11.53 ± 1.09 g/L and 12.10 ± 0.64 g/L was obtained on the 14th and 21st days of growth, respectively.

The data obtained indicate that after 7th day of submerged cultivation, all the strains studied produced the maximum EPS yield. The most promising EPS producers were strains of H. coralloides IBK-2332 (1.89 ± 0.12 g/L) and H. erinaceus IBK-2530 (1.90 ± 0.07 g/L).

Discussion

In our studies, H. coralloides IBK 2332, H. cirrhatum IBK 2393, and H. erinaceus IBK 2530 extracts demonstrate strong antibacterial effects against bacterial test cultures. At the same time, analyzing the available literature, we did not find data indicating the antimicrobial activity of H. cirrhatum fungi. Previous studies demonstrate that Hericium fungi are producers of secondary metabolites with antimicrobial properties [2, 32], [33], [34]. An aqueous extract from the fruiting bodies of H. erinaceus is known to accelerate wound healing. Various researchers have confirmed the antimicrobial effect of extracts of fruiting bodies of H. erinaceus that inhibited the growth of Bacillus cereus, B. subtilis, Enterococcus faecalis, S. aureus, P. aeruginosa, E. coli and Plesiomonas shigelloides [6, 16, 23, 34], [35], [36]. Data obtained by Han et al. and Song et al. show that ethyl acetate and methanol extracts from H. erinaceus fruiting bodies exhibit a high antibacterial effect against Micrococcus luteus and S. aureus, and moderate activity against Enterobacter cloacae and Streptococcus mutans. Studies have shown that some of these metabolites have antibacterial and antifungal properties [21, 24]. It was found that higher antimicrobial activity of mushroom extracts was observed against Gram-positive bacteria, including drug-resistant strains, such as methicillin-resistant [23]. Okamoto et al. established the antimicrobial potential of H. erinaceus and identified some bioactive molecules with antimicrobial activity against S. aureus, Salmonella enteritidis, Vibrio parahaemolyticus, and E. coli [37]. Our results correspond to the literature. Analyzing the data obtained, we note that the studied strains synthesize biologically active substances that are effective against the resistance to methicillin-resistant test bacterium S. aureus, which is known by various antibiotic resistance spectra.

Liu et al. studied various fractions of ethyl extracts of H. erinaceus mycelial biomass against Helicobacter pylori. All obtained samples had weak antibacterial activity (MIC from 250 to 500 μg/mL/mL) [38]. After purification and separation of the extracts by chromatography, an increase in the MIC to 12.5–50 μg/mL and 6.25–25 μg/mL was observed for fractions 1 and 2, respectively. Based on the obtained results, it can be assumed that during subsequent purifications of H. erinaceus IBK 2530 ethyl extract with MIC of 50 and 130 μg/mL to S. aureus, the antibacterial activity of the obtained samples increased. These data must be interpreted cautiously because the compositions of four fractions of H. coralloides ethyl acetate extract obtained in another research did not exhibit antibacterial activity against B. subtilis, S. aureus, E. coli, Botrytis cinerea, and Rhizoctonia solani [39].

Thus, comparing the obtained results with the literature data, it should be noted that H. cirrhatum IBK 2393, H. coralloides IBK 2332, and H. erinaceus IBK 2530 culture fluid extracts, as well as their biomass extracts, exhibit high antibacterial effect against Gram-positive bacteria such as S. aureus, as well as B. subtilis, which makes it possible to talk about the prospects of using these mushroom strains in the future as antibacterial agents. However, this requires further study and is another potential area of future research.

So far, many studies have focused on extracts obtained from fruiting bodies [1, 2, 6, 8, 16], [17], [18, 32, 34], [35], [36]. The current research was conducted by submerged cultivation, and fungal mycelium and culture fluid were used for extract preparation.

According to the literature data, the antibacterial effect of basidiomycetes is due to the presence of different biologically active compounds, including polysaccharides [1, 4, 7]. Previous studies have reported that the yield of extracellular polysaccharides during the cultivation of H. erinaceus ranges from 0.33 to 2.77 g/L depending on the carbon and nitrogen sources, minerals, vitamins, and the pH of the nutrient medium. Under optimal cultivation conditions, the maximum biomass yield in H. erinaceus reached 14.24 ± 0.45 g/L. At the same time, the maximum EPS production was observed on the 8th day of fungal cultivation (2.75 ± 0.27 g/L) [13]. In our research, the maximum biomass yield in H. erinaceus IBK 2530 was 8.04 ± 0.42 g/L, and the maximum EPS production we also observed after 7 days of fungal cultivation was 1.90 ± 0.07  g/L. Compared with literature data on other mushrooms, the maximum EPS production in Lentinus edodes was 0.8 g/L, in Pleurotus ostreatus 1.3 g/L, and in P. eryngii 1.0 g/L [29]. The results strongly depend on the effect of various sources of carbon and nitrogen on the productivity of biomass and extracellular polysaccharides, as was shown by Elisashvili et al. [29]. The highest EPS productivity was obtained on media with glucose or sodium gluconate as the carbon source and peptone оr liquid corn extract as the nitrogen source [29]. Our study did not aim to optimize the medium and increase biomass and EPS yield. Therefore, we used the composition of the media components whose effectiveness was proven by previous researchers: glucose 25.0 g/L, peptone 3.0 g/L, and yeast extract 2.0 g/L [29, 30]. It was a screening study of promising Hericium species and strains selected at the previous stage of our research. The most promising results were 17.45 ± 0.71 g/L and 12.10 ± 0.64 g/L biomass produced by H. cirrhatum IBK 2393 and H. coralloides IBK 2332, respectively, on the 21st day of submerged cultivation. According to our data, the EPS accumulation in culture liquid rather correlated with mushroom biomass yield. Interestingly, long-term submerged cultivation of these cultures to obtain EPS is not advisable. Among mushrooms tested, the maximum EPS we observed on the 7th of submerged cultivation. Similar results have been reported by Elisashvili after 7 days of cultivation of Agaricus sp. and Oudemansiella canarii [3].

In conclusion, Hericium extracts exhibit strong antibacterial activity against the Gram-positive bacteria S. aureus. Our results demonstrate that mushroom extracts had no effect against A. niger, P. polonicum, and M. globosus. On the 7th day of submerged cultivation, all the strains studied produced the maximum EPS yield (1.55–1.9 g/L). However, the EPS productivity of each strain decreased with the length of cultivation time. At the same time, an inverse correlation was observed for the accumulation of mycelial biomass. The maximum amount of biomass was accumulated on 14–21 days of fungal cultivation. Thus, Hericium fungi have significant potential for the development of new drugs with health benefits properties.

Corresponding author: Margarita Lomberg, Department of Mycology, M.G. Kholodny Institute of Botany of NAS of Ukraine, 2, Tereshchenkivska St., Kyiv, Ukraine, Phone: +38 (096) 524 19 196, E-mail: .

Funding source: This research has been funded by the Committee of Sciences of the Ministry of Education and Science of the Republic of Kazakhstan (Grant No. AP09258296).

  1. Research funding: This research was funded by the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (Grant No. AP09258296).

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Wasser, SP. Medicinal mushroom science: current perspectives, advances, evidences, and challenges. Biomed J 2014;37:345–56. https://doi.org/10.4103/2319-4170.138318.Search in Google Scholar PubMed

2. Agrawal, DC, Dhanasekaran, M, editors. Medicinal mushroom. Recent progress in research, 1st ed. Singapore: Springer; 2019.10.1007/978-981-13-6382-5Search in Google Scholar

3. Elisashvili, V. Submerged cultivation of medicinal mushrooms: bioprocesses and products. Int J Med Mushrooms 2012;14:211–39. https://doi.org/10.1615/intjmedmushr.v14.i3.10.Search in Google Scholar PubMed

4. Wasser, SP, editor. Biological features of medicinal macromycetes in culture. Kiev: Alterpres; 2012.Search in Google Scholar

5. Friedman, M. Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (lion’s mane) mushroom fruiting bodies and mycelia and their bioactive compounds. J Agric Food Chem 2015;63:7108–23. https://doi.org/10.1021/acs.jafc.5b02914.Search in Google Scholar PubMed

6. Thongbai, B, Rapior, S, Hyde, KD, Wittstein, K, Stadler, M. Hericium erinaceus, an amazing medicinal mushroom. Mycol Prog 2015;14:1–23. https://doi.org/10.1007/s11557-015-1105-4.Search in Google Scholar

7. Dmytriev, OP. Botany and mycology: modern horizons. Kyiv: Nash format; 2021:564 p.Search in Google Scholar

8. Mizuno, T. Bioactive substances in Hericium erinaceus. Pers. (Yamabushitake), and its medicinal utilization. Int J Med Mushrooms 1999;1:105–19. https://doi.org/10.1615/intjmedmushrooms.v1.i2.10.Search in Google Scholar

9. Reshetnikov, SV, Wasser, SP, Tan, KK. Higher Basidiomycota assource of antitumor and immunostimulating polysaccharides. Int J Med Mushrooms 2001;3:361–94.10.1615/IntJMedMushr.v3.i4.80Search in Google Scholar

10. Choudhary, S. Characterization and applications of mushroom exopolysaccharides. In: Singh, J, Gehlot, P, editors. New and future developments in microbial biotechnology and bioengineering. Recent advances in application of fungi and fungal metabolites: environmental and industrial aspects. Amsterdam: Elsevier B.V.; 2020.10.1016/B978-0-12-821007-9.00014-0Search in Google Scholar

11. Wang, JC, Hu, SH, Su, CH, Lee, TM. Antitumor and immunoenhancing activities of polysaccharide from culture broth of Hericium spp. Kaohsiung J Med Sci 2001;17:461–7.Search in Google Scholar

12. Wang, XY, Zhang, DD, Yin, JY, Nie, SP, Xie, MY. Recent developments in Hericium erinaceus polysaccharides: extraction, purification, structural characteristics, and biological activities. Crit Rev Food Sci Nutr 2019;59:96–115. https://doi.org/10.1080/10408398.2018.1521370.Search in Google Scholar PubMed

13. Malinowska, E, Krzyczkowski, W, Lapienis, G, Herold, F. Improved simultaneous production of mycelial biomass and polysaccharides by submerged culture of Hericium erinaceum: optimization using a central composite rotatable design (CCRD). J Ind Microbiol Biotechnol 2009;36:1513–27. https://doi.org/10.1007/s10295-009-0640-x.Search in Google Scholar PubMed

14. Wu, DT, Li, WZ, Chen, J, Zhong, QX, Ju, YJ, Zhao, J, et al.. An evaluation system for characterization of polysaccharides from the fruiting body of Hericium erinaceus and identification of its commercial product. Carbohydr Polym 2015;124:201–7. https://doi.org/10.1016/j.carbpol.2015.02.028.Search in Google Scholar PubMed

15. Wittstein, K, Rascher, M, Rupcic, Z, Lowen, E, Winter, B, Koster, RW, et al.. Corallocins A-C, nerve growth, and brain-derived neurotrophic factor-inducing metabolites from the mushroom Hericium coralloides. J Nat Prod 2016;79:2264–9. https://doi.org/10.1021/acs.jnatprod.6b00371.Search in Google Scholar PubMed

16. Wong, KH, Sabaratnam, V, Abdullah, N, Kuppusamy, UR, Naidu, M. Effects of cultivation techniques and processing on antimicrobial and antioxidant activities of Hericium erinaceus (Bull.: Fr.) Pers. extracts. Food Technol Biotechnol 2009;47:47–55.Search in Google Scholar

17. Shang, X, Tan, Q, Liu, R, Yu, K, Li, P, Zhao, GP. In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion’s Mane mushroom, Hericium erinaceus (Higher Basidiomycetes). Int J Med Mushrooms 2013;15:165–74. https://doi.org/10.1615/intjmedmushr.v15.i2.50.Search in Google Scholar PubMed

18. Shen, H-S, Shao, S, Chen, J-C, Zhou, T. Antimicrobials from mushrooms for assuring food safety. Compr Rev Food Sci Food Saf 2017;16:316–29. https://doi.org/10.1111/1541-4337.12255.Search in Google Scholar PubMed

19. Mustafin, KG, Biskо, NA, Blieva, RK, Al-Mаali, GA, Krupodorova, T, ZhB, N, et al.. Antioxidаnt and antimicrobial potentiаl of Ganoderma lucidum and Trametes versicolor. Turk Biyokim Derg 2022;47:483–9. https://doi.org/10.1515/tjb-2021-0141.Search in Google Scholar

20. Kim, DM, Pyun, CW, Ko, HG, Park, WM. Isolation of antimicrobial substances from Hericium erinaceum. Mycobiology 2000;28:33–8. https://doi.org/10.1080/12298093.2000.12015719.Search in Google Scholar

21. Han, SR, Jun, JA, Yang, HS, Oh, TJ. Comparison of physiological activity of solvent extracts from Hericium erinaceus. Indian J Sci Technol 2015;8:1–7. https://doi.org/10.17485/ijst/2015/v8i25/80496.Search in Google Scholar

22. Krupodorova, ТА, Barshteyn, VY, Zabeida, EF, Pokas, EV. Аntibacterial activity of macromycetes mycelia and culture liquid. Microbiol Biotechnol Lett 2016;44:246–53. https://doi.org/10.4014/mbl.1603.03003.Search in Google Scholar

23. Nikolovska-Nedelkoska, D, Atanasova-Pancevska, N, Karadelev, MP, Kungulovski, DV. Bactericidal activities of selected macrofungi extracts against Staphylococcus aureus. Zb Matice Srp Prir Nauk 2017;133:193–200. https://doi.org/10.2298/zmspn1733193n.Search in Google Scholar

24. Song, X, Gaascht, F, Schmidt‐Dannert, C, Salomon, CE. Discovery of antifungal and biofilm preventative compounds from mycelial cultures of a unique North American Hericium sp. fungus. Molecules 2020;25:963. https://doi.org/10.3390/molecules25040963.Search in Google Scholar PubMed PubMed Central

25. Bisko, N, Lomberg, M, Mykchaylova, O, Mytropolska N [Online]. IBK mushroom culture collection. In: Version 1.5. The IBK mushroom culture collection of the M.G. Kholodny Institute of Botany; 2022. Available from: https://www.gbif.org/dataset/148aefb6-cf88-443e-9780-b774ef7333e7 [Accessed via GBIF.org on 13 Jan 2023].Search in Google Scholar

26. Mykchаylova, O, Poyedіnok, N. Antimicrobial activity of Fomitopsis officinalis. Bondartsev & singer in pure culture. Innov Biosyst Bioeng 2021;5:220–7. https://doi.org/10.20535/ibb.2021.5.4.246668.Search in Google Scholar

27. Dyakov, MY, Kamzolkina, OV, Shtaer, OV, Bis’ko, NA, Poedinok, NL, Mikhailova, OB, et al.. Morphological characteristics of natural strains of certain species of basidiomycetes and biological analysis of antimicrobial activity under submerged cultural conditions. Microbiology 2011;80:274–85. https://doi.org/10.1134/s0026261711020044.Search in Google Scholar

28. Wiegand, I, Hilpert, K, Hancock, RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008;3:163–75. https://doi.org/10.1038/nprot.2007.521.Search in Google Scholar PubMed

29. Elisashvili, V, Wasser, SP, Tan, K-K, Chichua, D, Kachlishvili, E. Extracellular polysaccharide production by culinary-medicinal shiitake mushroom Lentinus edodes species depending on carbon and nitrogen source. Int J Med Mushrooms 2004;6:165–72. https://doi.org/10.1615/intjmedmushr.v6.i2.70.Search in Google Scholar

30. Bаbitskaya, VG, Scherba, VV, Mytropolskаya, NY, Bisko, NA. Exopolysacchаrides of some medicinal mushrooms: production and composition. Int J Med Mushrooms 2000;2:51–4.10.1615/IntJMedMushr.v2.i1.50Search in Google Scholar

31. Lomberg, M, Krupodorova, T, Krasinko, V, Mykchaylova, O. Antibacterial activity of culture filtrates and mycelia of the selected strains of macromycetes from genus Hericium. Bot Serb 2023;2:1–21.10.2298/BOTSERB2302241LSearch in Google Scholar

32. Alves, MJ, Ferreira, ICFR, Dias, J, Teixeira, V, Martins, A, Pintado, M. A review on anti-microbial activity of mushroom (Basidiomycetes) extracts and isolated compounds. Planta Med 2012;78:1707–18. https://doi.org/10.1055/s-0032-1315370.Search in Google Scholar PubMed

33. De Silva, DD, Rapior, S, Sudarman, E, Stadler, M, Xu, J, Alias, SA, et al.. Bioactive metabolites from macrofungi: ethnopharmacology, biological activities, and chemistry. Fungal Divers 2013;62:1–40. https://doi.org/10.1007/s13225-013-0265-2.Search in Google Scholar

34. Hyde, KD, Xu, J, Rapior, S, Rapior, S, Lumyong, S, Niego, AGT, et al.. The аmazing potential of fungi: 50 ways we can exploit fungi industrially. Fungal Divers 2019;97:1–136. https://doi.org/10.1007/s13225-019-00430-9.Search in Google Scholar

35. Khan, MA, Tania, M, Liu, R, Rahman, MM. Hericium erinaceus: an edible mushroom with medicinal values. J Integr Complement Med 2013;10:253–8. https://doi.org/10.1515/jcim-2013-0001.Search in Google Scholar PubMed

36. Jiang, S, Wang, S, Sun, Y, Zhang, Q. Medicinal properties of Hericium erinaceus and its potential to formulate novel mushroom-based pharmaceuticals. Appl Microbiol Biotechnol 2014;98:7661–70. https://doi.org/10.1007/s00253-014-5955-5.Search in Google Scholar PubMed

37. Okamoto, K, Sakai, T, Shimada, A, Shirai, R, Sakamoto, H, Yoshida, S, et al.. Antimicrobial chlorinated orcinol derivatives from mycelia of Hericium erinaceum. Phytochemistry 1993;34:1445–6. https://doi.org/10.1016/0031-9422(91)80050-b.Search in Google Scholar

38. Liu, JH, Li, L, Shang, XD, Zhang, JL, Tan, Q. Anti-Helicobacter pylori activity of bioactive components isolated from Hericium erinaceus. J Ethnopharmacol 2016;183:54–8. https://doi.org/10.1016/j.jep.2015.09.004.Search in Google Scholar PubMed

39. Kim, JY, Woo, E-E, Lee, IK, Yun, BS. New antioxidants from the culture broth of Hericium coralloides. J Antibiot 2018;71:822–5. https://doi.org/10.1038/s41429-018-0067-6.Search in Google Scholar PubMed

Received: 2022-10-14
Accepted: 2023-03-07
Published Online: 2023-04-24

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Molecular mechanisms and genetics of Alzheimer’s disease
  4. Short Communication
  5. A simple PCR-SSP method for detection of HLA-B*15:02, *15:13, and *15:21
  6. Research Articles
  7. The influence of CASP8 D302H gene variant in colorectal cancer risk and prognosis
  8. Silencing TCAB1 suppresses proliferation of hepatocellular carcinoma cells by inducing apoptosis
  9. Association of a haplotype in the NRG1 gene with schizophrenia: a case-control study
  10. Investigation of the roles of TGFβ1, CUG2, TGFBI genes, and thiol-disulfide balance on prostate cancer and metastasis
  11. The effect of krill oil on Wnt/β-catenin signaling pathway in acetaminophen-induced acute liver injury in mice
  12. Antiproliferative activity of Malus sylvestris Miller against HepG2 cell line with their antioxidant properties and phenolic composition
  13. Assessment of the effects of CNR1, FAAH and MGLL gene variations on the synthetic cannabinoid use disorder
  14. Screening of medicinal mushroom strains with antimicrobial activity and polysaccharides production
  15. The effects of Hericium erinaceus extracts on cell viability and telomerase activity in MCF-7 cells
  16. Neuroprotective effects of Cubebin and Hinokinin lignan fractions of Piper cubeba fruit in Alzheimer’s disease in vitro model
  17. Effects of kynurenic acid and choline on lipopolysaccharide-induced cyclooxygenase pathway
  18. Effects of PON1 QR192 genetic polymorphism and paraoxonase, arylesterase activities on deep vein thrombosis
  19. Evaluation of calcium/magnesium ratio in patients with type 2 diabetes mellitus
https://doi.org/10.1515/tjb-2022-0235
Keywords for this article
basidiomycetes; culture fluid; extracellular polysaccharide (EPS); Hericium; minimum inhibitory concentration (MIC); mycelium
Creative Commons
BY 4.0

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Molecular mechanisms and genetics of Alzheimer’s disease
  4. Short Communication
  5. A simple PCR-SSP method for detection of HLA-B*15:02, *15:13, and *15:21
  6. Research Articles
  7. The influence of CASP8 D302H gene variant in colorectal cancer risk and prognosis
  8. Silencing TCAB1 suppresses proliferation of hepatocellular carcinoma cells by inducing apoptosis
  9. Association of a haplotype in the NRG1 gene with schizophrenia: a case-control study
  10. Investigation of the roles of TGFβ1, CUG2, TGFBI genes, and thiol-disulfide balance on prostate cancer and metastasis
  11. The effect of krill oil on Wnt/β-catenin signaling pathway in acetaminophen-induced acute liver injury in mice
  12. Antiproliferative activity of Malus sylvestris Miller against HepG2 cell line with their antioxidant properties and phenolic composition
  13. Assessment of the effects of CNR1, FAAH and MGLL gene variations on the synthetic cannabinoid use disorder
  14. Screening of medicinal mushroom strains with antimicrobial activity and polysaccharides production
  15. The effects of Hericium erinaceus extracts on cell viability and telomerase activity in MCF-7 cells
  16. Neuroprotective effects of Cubebin and Hinokinin lignan fractions of Piper cubeba fruit in Alzheimer’s disease in vitro model
  17. Effects of kynurenic acid and choline on lipopolysaccharide-induced cyclooxygenase pathway
  18. Effects of PON1 QR192 genetic polymorphism and paraoxonase, arylesterase activities on deep vein thrombosis
  19. Evaluation of calcium/magnesium ratio in patients with type 2 diabetes mellitus
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/tjb-2022-0235/html
Scroll to top button